170984-13-1

Upstream product

• 98-88-4 benzoyl chloride 
• 170983-95-6 9-N-<(2'-deoxy-β-D-ribo-pentofuranosyl)methyl>adenine 
• 177171-88-9 ((2R,4S,5R)-4-Benzyloxy-5-benzyloxymethyl-tetrahydro-furan-2-yl)-methanol 
• 170984-16-4 2,5-anhydro-1-(adenin-9-yl)-4,6-di-O-benzyl-1,3-dideoxy-D-allitol 
• 177171-89-0 1-C-(methanesulfonyloxy)methyl-3,5-dibenzyl-2-deoxy-β-D-ribose 

Downstream Products

• 180000-29-7 9-N-[5'-O-(4,4'-dimethoxytrityl)-(2'-deoxy-β-D-ribo-pentofuranosyl)methyl]-N⁶-benzoyladenine 
• 180000-31-1 Succinic acid mono-{(2R,3S,5R)-5-(6-benzoylamino-purin-9-ylmethyl)-2-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-tetrahydro-furan-3-yl} ester 
• 726186-36-3 N-{9-[4-(tert-butyl-dimethyl-silanyloxy)-5-hydroxymethyl-tetrahydro-furan-2-ylmethyl]-9H-purin-6-yl}-benzamide 

Relevant academic research and scientific papers

Homo-N-oligonucleotides (N1/N9-C1′ methylene bridge oligonucleotides): Nucleic acids with left-handed helicity

Oligonucleotides containing a methylene bridge between N1 or N9 of the heterocyclic base and C1′ of the pentofuranosyl ring (homo-N- oligonucleotides) were synthesized. Melting curves revealed that such homo-type oligomers could cross-pair with complement

Antiviral c-nucleoside derivatives

The present invention is composed of a nucleoside derivative of the following general formula ?I!: STR1 (wherein B represents adenin-9-ylmethyl, guanin-9-ylmethyl, hypoxanthin-9-ylmethyl, thymin-1-ylmethyl, uracil-1-ylmethyl, or cytosin-1-ylmethyl; X and

Synthesis from homo-N-nucleosides, a series of C1, branched chain nucleosides

Homo-N-desoxynucleosides were synthesized starting from 2-deoxy-D-ribose using a one step epoxidation-ring closure approach. The configuration of the nucleosides were proven using NMR and X-ray analysis.